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γ-aminobutyric acid type B (GABA-B) receptor mediates the inhibitory transmission of
γ-aminobutyric acid in the mammalian nervous system, being present in neurons and
also in glial cells. Recently the presence of GABA-B has been demonstrated in Schwann
cells (SC) suggesting its contribution in regulating the cell fate, maturation, and plasticity.
Here, we further support the functional presence of GABA-B receptor in SC plasma
membrane. By confocal microscopy immunofluorescence we provide evidences that
GABA-B localization on the cell elongated processes correlates with the morphological
changes occurring in the differentiated SC. In vivo most of the GABA-B receptors seem
to be present in non-myelinating SC, which are committed to ensheath the nociceptive
fibers. Therefore, we argue that GABA-B receptors do not control exclusively the in vivo
differentiation yielding the myelinating SC, but are also fundamental in regulating the
SC plasticity versus the non-myelinating state. Data from the literature and our recent
findings corroborate the role of the GABAergic system and GABA-B receptors in the
peripheral nervous system, opening new perspectives on the mechanisms controlling the
differentiation of SC.
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INTRODUCTION
Unlike neurons in the central nervous system (CNS), the periph-
eral nervous system (PNS) has the capacity to re-growth after a
damage. This regenerative capacity mainly rests on the plasticity
of Schwann cells (SC) and on their ability to switch between dif-
ferentiation states (Jessen and Mirsky, 2005). SC, that normally
produce an insulating myelin sheath around the axons, stimulate
the survival and re-growth of injured nerves. Regenerative de-
and re-differentiation as well as developmental differentiation,
are tightly controlled by a balance of positive/negative regulators
of SC maturation (Jessen and Mirsky, 2005, 2008). The com-
prehension of the mechanisms that contribute to SC plasticity
are important not only to understand basic principles regulat-
ing SC biology and neuronal regeneration, but also because some
of the molecules involved may act as modulators of periph-
eral neuropathies and associated neuropathic pain (Jessen and
Mirsky, 2008). In recent years, the increased understanding of
the cellular mechanisms controlling neuron-glial crosstalk in the
PNS has focused on classic neurotransmitters, such as adenosine
triphosphate (ATP) or γ-aminobutyric acid (GABA) (Fields and
Stevens-Graham, 2002;Magnaghi et al., 2009). Here we survey the
latest findings on the involvement of GABA system in SC, particu-
larly via type B (GABA-B) receptor, assessing its potential as novel
tool to regulate SC fate and plasticity.
GABA-B RECEPTOR IN THE PNS
GABA-B RECEPTOR
In the mammalian nervous system the GABA-B receptor is one of
the native targets of GABA, the main inhibitory neurotransmitter
(Bowery et al., 2002; Olsen and Sieghart, 2008). GABA-B is a dis-
tinct, baclofen-sensitive, metabotropic receptor, member of the
seven transmembrane G-protein-coupled receptor superfamily.
The intracellular signaling involves the activation of the adenylate
cyclase second messenger systems and/or calcium and potassium
channels activities (Bowery et al., 2002). GABA-B receptor is a
heterodimer composed of two subunits, respectively GABA-B1
that is responsible for the ligand binding (Kaupmann et al., 1997,
1998; Jones et al., 1998; White et al., 1998; Kuner et al., 1999; Pfaff
et al., 1999), and GABA-B2, which is necessary for the trafficking
of the heterodimer to the cell surface and for signal transduction
(Ng et al., 1999).
GABA-B RECEPTOR IN THE PNS
The presence of GABA and its receptors in peripheral nerves
date back to the 1980’s (Brown and Marsh, 1978; Brown et al.,
1979; Jessen et al., 1979; Morris et al., 1983; Olsen et al.,
1984; Bhisitkul et al., 1987), but only recent findings yielded
by reverse transcriptase-polymerase chain reaction, western blot,
and immunohistochemistry, have clearly stated that GABA-B
receptors are present in the PNS (Magnaghi et al., 2004, 2006;
Magnaghi, 2007).
GABA-B RECEPTOR IN THE PNS OF KNOCKOUT MICE
The absence of GABA-B1 receptors has been confirmed in dif-
ferent nervous and non-nervous tissues of GABA-B1 knock-
out mice (Schuler et al., 2001). Hence, these mice are a good
model to study the biochemical, morphological, and physiolog-
ical consequences of the constitutive loss of GABA-B functions
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(Schuler et al., 2001). Recently, it has been shown that lack of
GABA-B receptor activity in GABA-B1 knockout mice affects
PNS myelination process, which in turn can contribute to the
sensory phenotype observed (Magnaghi et al., 2008). Indeed,
GABA-B1 deficient mice exhibited morphological and molecu-
lar changes in the peripheral myelin, including increases in the
number of irregular fibers and in the expression levels of the
myelin proteins, such as peripheral myelin protein 22 (PMP22)
and myelin protein zero (P0). The density of small myelinated
fibers and small neurons of the lumbar dorsal root ganglia
(DRG) was raised in GABA-B1 deficient mice. These changes
were also associated to altered gait behavior and pain perception,
as well as with hyperalgesia to thermal stimuli (Magnaghi et al.,
2008).
GABA-B RECEPTOR IN SC
In the PNS GABA-B receptors are mostly localized on the SC
(Magnaghi et al., 2004; Magnaghi, 2007; Faroni et al., 2011).
In these cells, GABA-B receptors proved to be negatively cou-
pled to the adenylate cyclase system (Magnaghi et al., 2004),
controlling SC proliferation and, overall, the myelin gene expres-
sion, both in vitro and in vivo (Magnaghi et al., 2004, 2008).
Indeed, the activation of GABA-B receptor with the specific ago-
nist baclofen counteracted the forskolin-induced SC proliferation
at 5 days in vitro, with a reduction of the percentage of BrdUrd
immunopositive SC (Magnaghi et al., 2004). In addition, GABA-
B receptor activation decreased the expression levels of some
myelin proteins, like PMP22, P0, connexin 32, and the myelin-
associated glycoprotein (MAG) (Magnaghi et al., 2004). Given
that the enzyme adenylate cyclase is able to regulate SC prolifera-
tion (Lee et al., 1999; Mirsky and Jessen, 1999) and the expression
of specific myelin proteins (Suter et al., 1994; Scherer et al., 1995;
Lee et al., 1999), it was conceivable to hypothesise that the GABA-
B-induced decrease in cAMP levels accounts for the changes in
cell proliferation and myelin gene expression in SC.
However, the trafficking of the GABA-B receptor complex to
the plasma membrane is also crucial for its functional activity
(Bettler and Tiao, 2006). Recent studies evaluated the subcellu-
lar localization of GABA-B receptors in SC by protein fractioning
and western blot analysis. Two bands of 130 kDa and 100 kDa,
corresponding to the GABA-B 1a and 1b native isoforms respec-
tively (Kaupmann et al., 1997; Ige et al., 2000), were found in
the membrane-enriched fraction of SC. By contrast, very faint
bands likely corresponding to the GABA-B1 in the secretory
granules still persisted in the cytoplasmic fraction (Figure 1A).
Accordingly, in SC treated with the enzyme chymotrypsin, which
cleaves the peptidic bonds of proteins localized in the outer
plasmamembrane, the two bands corresponding to the GABA-B1
isoforms disappeared, whereas very weak bands still correspond-
ing to the cytoplasmic fraction appeared (Figure 1B). A further
evaluation of the GABA-B expression in SC membrane was done
by immunofluorescence and confocal laser scanner microscopy
(CLSM). f-actin is a protein producing a polymer that lies beneath
the plasma membrane (Pollard and Borisy, 2003), and that is
also present in lateral microvilli of SC (Trapp et al., 1989).
As a valuable tool for f-actin labeling (Faulstich et al., 1983;
Barber et al., 2004), the tetramethyl rhodamine isothiocyanate
(TRITC)-fluorescent conjugate of phalloidin is useful to highlight
the SC perimeter and shape (red in Figure 1C). GABA-B1 sub-
unit was detected in SC cytoplasm and in cellular processes (green
in Figure 1C), while GABA-B2 was found in SC body compart-
ment (green in Figure 1C). Although GABA-B1 and GABA-B2
appeared generally spread throughout the SC body, the cyto-
plasmic presence was not unexpected because data from the
literature indicates that GABA-B receptors may function as co-
regulator of nuclear transcription factors such as ATF-4 or CREB-
2 (Charles et al., 2003). However, merge images revealed that both
GABA-B1 and GABA-B2 receptors were localized in the SCmem-
branes, likely bounded to the f-actin filaments tracing the cells
border (yellow in Figure 1C). By processing the y-axis projec-
tions of the confocal images of GABA-B/f-actin co-localizations,
GABA-B1 and GABA-B2 resulted particularly enriched at the
membrane surfaces ensheathing the cell body compartments
(green in Figure 1D), although the GABA-B labeling was also
present at the cell borders outlined by the f-actin cytoskele-
ton (yellow in Figure 1D). As expected, all these observations
further confirmed the cell membrane localization of GABA-B
receptors in SC.
DOES GABA-B HAVE A ROLE IN SC DIFFERENTIATION?
SC committed in the process of myelination differentiate in vivo
in response to contact with axons (Aguayo et al., 1976; Weinberg
and Spencer, 1976). In vitro the same phenomenon of differ-
entiation needs the presence of serum plus agents rising cAMP,
like forskolin or 8Br-cAMP (Sobue et al., 1986; Morgan et al.,
1991). In this context, agents modulating GABA-B receptors and
in turn cAMP levels may thus participate in the control of SC
differentiation and myelination processes.
The rearrangement of actin cytoskeleton is critical for SC dif-
ferentiation and myelination (Fernandez-Valle et al., 1997; Gatto
et al., 2003). During differentiation, SC change from a flat shape
into a spindle-shaped phenotype; these cells present a reorgani-
zation in f-actin cytoskeleton and the appearance of bundles of
stress fibers (Li et al., 2003). In such a way, the SC that assume
the bipolar-shaped morphology resemble to the cells starting the
myelination process in vivo.
Data collected in our laboratory, by means of co-localization
studies (Bolte and Cordelieres, 2006), evidenced that the
forskolin-induced SC differentiation correlates with a redis-
tribution of GABA-B1 and GABA-B2 receptors on the SC
surface. Indeed, in the undifferentiated SC (Figure 2A), the
GABA-B1 receptor was localized on the protruding distal tips
(arrows in Figure 2A magnification). When the SC differentia-
tion starts, with changes in f-actin distribution and morphol-
ogy (Figure 2B), GABA-B1 localized in the elongated regions,
where the SC assumed the typical spindle-shaped morphol-
ogy (arrows in Figure 2B magnification). In these selected
regions the co-localization of f-actin and GABA-B1 receptors
was 94.1 ± 6.7%. At the same time, in undifferentiated SC
GABA-B2 showed a spread distribution (white in Figure 2C
magnification), which turned to be localized in specific sites
when, the SC differentiated and became elongated (Figure 2D).
For instance, in these sites the f-actin boundaries were strictly
assembled, SC cytoplasm extruded and the GABA-B2 receptor
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FIGURE 1 | GABA-B receptor is localized in plasma membranes of rat
SC. (A) SC cultures were grown in Dulbecco’s modified Eagle’s medium
with 10% fetal calf serum and they were highly pure, as characterized with
a specific protein marker S100. Western immunoblot was then performed
on the different SC subcellular protein fractions (nuclear, cytosolic, and
membrane-enriched) separated by ultracentrifugation at 100,000 g. The
antibody anti-GABA-B1 [1:250 (Magnaghi et al., 2004)] recognized two
bands of ∼130 kDa and 100 kDa, corresponding to the 1a and 1b isoforms
of native receptors in the membrane-enriched fraction of SC (Kaupmann
et al., 1997; Ige et al., 2000). GABA-B1 was absent in the nuclear-enriched
fraction, whereas two faint bands, likely corresponding to the GABA-B1 in
the secretory granules, still appeared in the cytosolic-enriched fraction of
SC. Equal loading was evaluated by western blot against alpha-tubulin.
(B) GABA-B1 immunoblot of chymotrypsin-treated SC (+) showed very
weak bands likely corresponding to the residual receptors in the
cytoplasmic fraction, while two GABA-B1 bands were present in the whole
protein extract from untreated SC (−). Equal protein loading was
evaluated by immunoblot of alpha-tubulin. (C) Immunofluorescence and
CLSM. The cellular cytoskeleton was revealed by phalloidin-TRITC staining
of f-actin (1:250, in red). GABA-B receptor detection was done with
Alexa-488 (in green). Merge images of GABA-B1 and GABA-B2 (in yellow)
show that both receptor subunits are expressed throughout the SC and
co-localize with f-actin at the cell border surface (arrows). (D) Progressive
y-axis projections of SC merge images revealing that both GABA-B1 and
GABA-B2 receptors were present at cell membrane surfaces (arrows) and
ensheath the cell body compartments. Negative GABA-B controls for
specificity showed only phalloidin-TRITC immunostaining (data not shown).
Scale bars 20μm.
immunopositivity was very bright (arrows in Figure 2D magnifi-
cation); the co-localization of f-actin and GABA-B2 receptors was
86.3 ± 9.7%.
The peculiar localization of GABA-B receptors on the elon-
gations, tips, and bipolar processes, when the SC are induced
to differentiate with forskolin, supports the proposed role of
GABA-B receptors for SC differentiation. Moreover, this local-
ization suggests “how” and “where” the GABA-B receptors are
present. Both features may be an important requirement for
the rearrangements associated to SC differentiation and for the
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FIGURE 2 | Continued
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FIGURE 2 | GABA-B receptor localization changes in differentiated SC
in vitro and in vivo. Forskolin treatment (100μM for 8 days)-induced
strong f-actin cytoskeleton-based change in SC. Indeed, control SC (no
forskolin) exhibited a polymerized f-actin wreath-like structure (A,C left
panels in red), while forskolin treatment prompted the cells to present a
stereotypical bipolar spindle-shape and elongated processes (B,D left
panels in red). (A) and (B) Immunoflorescence for GABA-B1, (C) and (D)
Immunoflorescence for GABA-B2, in undifferentiated and differentiated SC
respectively. The GABA-B receptor and f-actin merge images revealed a
different localization of GABA-B in the cell compartments, likely depending
by high cAMP levels induced with forskolin. In all immunofluorecence the
GABA-B detection was done with Alexa-488 (in green) while
phalloidin-TRITC stained f-actin (1:250, in red). Merge images (in yellow)
showing that f-actin/GABA-B co-localizations changed in distribution
between undifferentiated and differentiated SC. Four high magnification
images were done with LaserPix software (Bio-Rad Lab), based on
Pearson’s correlation coefficient with Costes’approach [reviewed in Bolte
and Cordelieres (2006)]. LaserPix allows to superimpose a white mask
onto the merge images, so that co-localized pixels of f-actin and GABA-B
receptor are easily revealed as white dots. The average signal
intensity/total pixels for white dots were calculated (104.15 undifferentiated
vs. 92.24 differentiated SC, signal intensity/total pixels for GABA-B1;
106.91 undifferentiated vs. 83.54 differentiated SC, signal intensity/total
pixels for GABA-B2). In undifferentiated SC GABA-B1 was present on cell
protruding tips (arrows in A high magnification), while GABA-B2 was
spread through the cytoplasm (C high magnification). After differentiation,
the elongated processes of SC presented a white co-localization for both
GABA-B receptors and f-actin (arrows in B and D high magnification). In
these regions the co-localization of f-actin and GABA-B1 receptors was
94.1 ± 6.7%, while that of f-actin and GABA-B2 receptors was
86.3 ± 9.7%. GABA-B receptor was also analyzed in myelinating and
non-myelinating SC. (E) Immunofluorescence in vivo in rat fibers of the
sciatic nerve to evaluate the co-localization of GABA-B receptor and MAG
[1:200, a specific protein of the adaxonal membrane of myelinating SC,
(Scherer and Arroyo, 2002)]. Some GABA-B1 positive SC were distributed
along axons (in green) without signs of co-localization with MAG (in red).
(F) Same result was evident at high magnification, whereas GABA-B1
labeled the SC cytoplasm (asterisk), bordering the nerve fiber (arrowheads)
as well as labeling the axon (arrows), but no sign of co-localization with
MAG were shown. (G) In rat coronal section of rat sciatic nerve was
assessed the co-localization of GABA-B receptor and GFAP [1:250, a
specific marker of non-myelinating SC (Jessen and Mirsky, 1984)]. Several
SC were double-stained for GABA-B1 (green) and GFAP (red) showing
some co-localization in SC (yellow). (H) Immunofluorescence in vivo in rat
saggital section of DRG to assess GABA-B receptor (in green) in the
afferent sensitive fibers. Soma of sensitive neurons were GABA-B positive
(arrows, left panel). The small sensitive fibers were labeled in red with
FluoroMyelinTM (1:300). Several sensitive fibers were also immunopositive
for GABA-B1 (green, left panel) with a preferential localization in
non-myelinating SC (asterisk). No GABA-B1 was present in rat sciatic
sections used as negative control (right panel, lack of GABA-B1 antibody).
Nuclei were stained with dapi. Scale bars 20μm.
establishment of the complex machinery regulating the myelina-
tion program in vivo.
The forskolin-induced GABA-B redistribution in SC seems
to be specific, in contrast with the localization of neuregulins
alpha and beta, which are differently affected by forskolin (Raabe
et al., 2004). Indeed, in untreated SC both neuregulins are co-
distributed throughout the cytoplasm, cell processes, and mostly
excluded from the nucleus. After forskolin treatment the neureg-
ulins change becoming either perinuclear or nuclear for alpha
and beta, respectively (Raabe et al., 2004). In addition, the nerve
growth factor (NGF) receptor is largely present at the distal ends
of the SC, suggesting a supplementary function for this recep-
tor during SC migration, development or ensheathing of axons
(Assouline and Pantazis, 1989). However, the forskolin-induced
GABA-B redistribution may be dependent from SC differentia-
tion, but may be also a consequence of the reorganization of the
SC actin cytoskeleton.
GABA-B RECEPTOR IS EXPRESSED IN NON-MYELINATING AND/OR
MYELINATING SC
SC are very plastic cells that may switch between the undifferenti-
ated and differentiated states. As a consequence SC may assume
the non-myelinating and/or myelinating condition respectively
(Jessen andMirsky, 2005, 2008). This is relevant for the axon-glial
crosstalk, for the development of sensory or motor functions, and
for nerve regeneration after an injury.
The findings gathered from GABA-B1 knockout mice suggest
the importance of GABA-B in non-myelinating SC regulating
the sensory functions (Magnaghi et al., 2008), nevertheless the
literature in this regard is still poor.
In theory, the SC that myelinate in vivo are generally con-
sidered comparable to SC that differentiate in vitro. In this
context, rat nerve fibers were evaluated for the co-localization
of GABA-B1 receptor and MAG, a specific protein localized on
the inner/adaxonal membrane in the myelinating SC and in the
Schmidt-Lanterman incisures of non-compact myelin (Scherer
and Arroyo, 2002). Some GABA-B1 positive SC were present in
the nerve, distributed along axons (Figure 2E in green) but no sig-
nificant co-localization withMAG (in red) was evident, neither in
the adaxonal membrane nor in the Schmidt-Lanterman incisures
(Figures 2E,F in yellow). The lack of co-localization of GABA-
B and MAG in vivo, indicates that GABA-B receptors are not
preferentially involved in the SC committed to myelinate. Indeed,
several SC in the coronal section of rat sciatic nerve were double-
stained for GABA-B1 (green) and for the glial fibrillary acidic
protein (GFAP, in red) showing co-localizations in SC (yellow in
Figure 2G). Given that GFAP is a marker of non-myelinating SC
in the PNS (Jessen andMirsky, 1984), this result strength the pref-
erential localization of GABA-B1 in these SC deputed to surround
the axons of small sensitive neurons.
The localization of GABA-B1 in non-myelinating SC was
further supported by the analysis of sensory DRG. The non-
myelinated fibers are generally known to be sensitive fibers
entering the DRG (Markenson, 1996). As expected, analyzing
the coronal sections just at the border between the sensitive
dorsal root and the DRG structure, the soma of some sensory
neurons of DRG showed a bright immunopositivity for GABA-
B receptors (arrows in Figure 2H, left panel). Contemporarily,
also several sensitive fibers entering the DRG, which are light
myelinated fibers (A delta fibers) or non-myelinated fibers
(C fibers), were GABA-B1-immunopositive (green Figure 2H,
left panel). However, the GABA-B1-immunopositive fibers were
not tightly connected to the myelin rings (red Figure 2H, left
panel) corroborating the preferential GABA-B1 localization in the
non-myelinating SC that surround the groups of axons (green
Figure 2H, left panel).
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Although other analysis are needed to support this hypothesis,
our results indicate an interesting participation of GABA-B recep-
tors in the differentiation/de-differentiation processes occurring
in SC. Indeed, the GABA-B receptors at the SC tips and edges
may be relevant when the SC are committed to become non-
myelinating SC.
CONCLUSION
The observations presented in this paper, gathered from the
literature and from our findings, stated that GABA-B recep-
tors are present and functional active in SC of the PNS. The
GABA-B receptor implication in the commitment of SC into the
myelination program might represent a fascinating functional
significance for their localization on the elongated parts of the
differentiated SC. However, the GABA-B-mediated control of the
differentiation/de-differentiation may be primarily relevant when
SC are committed to become non-myelinating SC, thus form-
ing the peripheral nociceptive fibers. In our opinion this is the
main significance of GABA-B1 presence in SC. The efforts are
now toward the perspective to demonstrate the role of GABA-B1
in non-myelinating SC. However, some questions are still open.
Does a specific GABA-B1 receptor ablation affect SC or sensory
neurons? Is the GABA-B receptor expression developmentally
regulated? Does it co-localize with other different GABA receptors
and/or proteins? The answers to these questions will shed light on
the complexity of the functional presence of GABA-B receptors in
the PNS.
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